Skip to main content
Equibles

Mark Chin

Board Member

Disc Medicine, Inc. (IRON)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Mark Chin

Mark Chin is recorded as Board Member at Disc Medicine, Inc. (IRON). Earlier roles on record: Board Member at Iterum Therapeutics plc (ITRMF) until December 31, 2023. Iterum Therapeutics plc reported in an 8-K filed December 29, 2023 that Mark Chin resigned as member of the Board of Directors, effective December 31, 2023. Enliven Therapeutics, Inc. reported in an 8-K filed March 1, 2023 that Mark Chin resigned as Board, effective February 23, 2023. Disc Medicine, Inc. reported in an 8-K filed December 29, 2022 that Mark Chin was appointed Class II director, effective December 29, 2022.

“On December 28, 2023, Mark Chin informed management that he would be resigning as a member of the Board of Directors of Iterum Therapeutics plc (the "Company") with effect from December 31, 2023.”
Iterum Therapeutics plc Form 8-K, filed December 29, 2023 · Read the filing
“Pursuant to the Merger Agreement, on February 23, 2023, immediately prior to and effective upon the closing of the Merger, David M. Mott, David Bonita, M.D., Mark Chin, Edward Conner, M.D., Carl Goldfischer, M.D., Barbara J. Dalton, Ph.D, and Laura Williams, M.D., MPH, resigned from the Board and committees of the Board on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices.”
Enliven Therapeutics, Inc. Form 8-K, filed March 1, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Disc Medicine, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.